Skip to main content
Top
Published in:

27-01-2024 | Mutism | Research

National multicentered retrospective review of clinical and intraoperative factors associated with the development of cerebellar mutism after pediatric posterior fossa tumor resection

Authors: Michelle M. Kameda-Smith, Malavan Ragulojan, Cameron Elliott, Lori Bliss, Hanna Moore, Nicholas Sader, Mosaab Alsuwaihel, Michael K. Tso, Ayoub Dakson, Olufemi Ajani, Blake Yarascavitch, Adam Fleming, Vivek Mehta, Minoo Aminnejad, Forough Farrokhyar, Sheila K. Singh, on behalf of the McMaster Pediatric Brain Tumour Study Group (PBTSG) and the Canadian Neurosurgery Research Collaborative (CNRC)

Published in: Child's Nervous System | Issue 5/2024

Login to get access

Abstract

Background

Cerebellar mutism (CM) is characterized by a significant loss of speech in children following posterior fossa (PF) surgery. The biological origin of CM remains unclear and is the subject of ongoing debate. Significant recovery from CM is less likely than previously described despite rigorous multidisciplinary neuro-rehabilitational efforts.

Methods

A national multi-centered retrospective review of all children undergoing PF resection in four midsized Canadian academic pediatric institutions was undertaken. Patient, tumor and surgical factors associated with the post-operative development of CM were reviewed. Retrospective identification of PF surgery patients including those developing and those that did not (internal control).

Results

The study identified 258 patients across the 4 centers between 2010 and 2020 (mean age 6.73 years; 42.2% female). Overall, CM was experienced in 19.5% of patients (N = 50). Amongst children who developed CM histopathology included medulloblastoma (35.7%), pilocytic astrocytoma (32.6%) and ependymoma (17.1%). Intraoperative impression of adherence to the floor of the 4th ventricle was positive in 36.8%. Intraoperative abrupt changes in blood pressure and/or heart rate were identified in 19.4% and 17.8% of cases. The clinical resolution of CM was rated to be complete, significant resolution, slight improvement, no improvement and deterioration in 56.0%, 8.0%, 20.0%, 14.0% and 2.0%, respectively. In the cohort of children who experienced post-operative CM as compared to their no-CM counterpart, proportionally more tumors were felt to be adherent to the floor of the 4th ventricle (56.0% vs 49.5%), intraoperative extent of resection was a GTR (74% vs 68.8%) and changes in heart rate were noted (≥ 20% from baseline) (26.0% vs 15.9%). However, a multiple regression analysis identified only abrupt changes in HR (OR 5.97, CI (1.53, 23.1), p = 0.01) to be significantly associated with the development of post-operative CM.

Conclusion

As a devastating surgical complication after posterior fossa tumor surgery with variable clinical course, identifying and understanding the operative cues and revising intraoperative plans that optimizes the child’s neurooncological and clinical outcome are essential.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
National multicentered retrospective review of clinical and intraoperative factors associated with the development of cerebellar mutism after pediatric posterior fossa tumor resection
Authors
Michelle M. Kameda-Smith
Malavan Ragulojan
Cameron Elliott
Lori Bliss
Hanna Moore
Nicholas Sader
Mosaab Alsuwaihel
Michael K. Tso
Ayoub Dakson
Olufemi Ajani
Blake Yarascavitch
Adam Fleming
Vivek Mehta
Minoo Aminnejad
Forough Farrokhyar
Sheila K. Singh
on behalf of the McMaster Pediatric Brain Tumour Study Group (PBTSG) and the Canadian Neurosurgery Research Collaborative (CNRC)
Publication date
27-01-2024
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 5/2024
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-024-06292-0

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest

How can you integrate PET into your practice? (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest